Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Girard

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|February 3, 2006
Insulin's effect on the liver: "direct or indirect?" continues to be the questionJean Girard
Nephrologie & Therapeutique|June 5, 2017
[Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment]Jean Girard
Medecine Sciences : M/S|November 1, 2003
[Contribution of free fatty acids to impairment of insulin secretion and action: mechanism of beta-cell lipotoxicity]Jean Girard
Biochimie|October 13, 2017
Glucagon, a key factor in the pathophysiology of type 2 diabetesJean Girard
Medecine Sciences : M/S|April 8, 2006
[Contribution of free fatty acids to impairment of insulin secretion and action. mechanism of beta-cell lipotoxicity]Jean Girard
Diabetes & Metabolism|February 7, 2009
EditorialJean Girard, Serge Halimi
The Journal of Clinical Investigation|March 5, 2008
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceCatherine Postic, Jean Girard
Soins; La Revue De Reference Infirmiere|May 24, 2008
[Endocannabinoid type 1 receptor antagonists]Jean Girard, Jean-Pierre Sauvanet
Medecine Sciences : M/S|October 28, 2008
[Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP]Céline Robichon, Jean Girard, Catherine Postic
Biochimie|March 1, 2005
Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liverRenaud Dentin, Jean Girard, Catherine Postic
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|February 3, 2006
Insulin's effect on the liver: "direct or indirect?" continues to be the questionJean Girard
Nephrologie & Therapeutique|June 5, 2017
[Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment]Jean Girard
Medecine Sciences : M/S|November 1, 2003
[Contribution of free fatty acids to impairment of insulin secretion and action: mechanism of beta-cell lipotoxicity]Jean Girard
Biochimie|October 13, 2017
Glucagon, a key factor in the pathophysiology of type 2 diabetesJean Girard
Medecine Sciences : M/S|April 8, 2006
[Contribution of free fatty acids to impairment of insulin secretion and action. mechanism of beta-cell lipotoxicity]Jean Girard
Diabetes & Metabolism|February 7, 2009
EditorialJean Girard, Serge Halimi
The Journal of Clinical Investigation|March 5, 2008
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceCatherine Postic, Jean Girard
Soins; La Revue De Reference Infirmiere|May 24, 2008
[Endocannabinoid type 1 receptor antagonists]Jean Girard, Jean-Pierre Sauvanet
Medecine Sciences : M/S|October 28, 2008
[Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP]Céline Robichon, Jean Girard, Catherine Postic
Biochimie|March 1, 2005
Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liverRenaud Dentin, Jean Girard, Catherine Postic
Pageof 7